Variability of Stimulated Brillouin Scattering from NIF Hohlraums
Explore the source record for details and available documents.
SEARCH · Search NASA
Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Explore the source record for details and available documents.
The invention provides a method for forming a patterned material layer on a structure, by condensing a vapor to a solid condensate layer on a surface of the structure and then localized removal of selected regions of the condensate layer by directing a beam of energy at the selected regions, exposing the structure at the selected regions. A material layer is then deposited on top of the solid condensate layer and the exposed structure at the selected regions. Then the solid condensate layer and regions of the material layer that were deposited on the solid condensate layer are removed, leaving a patterned material layer on the structure.
The invention provides a method for forming a patterned material layer on a structure, by condensing a vapor to a solid condensate layer on a surface of the structure and then localized removal of selected regions of the condensate layer by directing an ion beam at the selected regions, exposing the structure at the selected regions. A material layer is then deposited on top of the solid condensate layer and the exposed structure at the selected regions. Then the solid condensate layer and regions of the material layer that were deposited on the solid condensate layer are removed, leaving a patterned material layer on the structure.
Explore the source record for details and available documents.
Abstract not provided.
Abstract not provided.
Hydraulic fracturing is the process of fracturing rock formations with high-pressure water-based fluids. In Enhanced Geothermal Systems (EGS) hydraulic fracturing is carried out by injecting high-pressure fluids into the Hot Dry Rocks (HDR) under carefully controlled conditions. The fluid used for fracturing is an important component for EGS, not only concerning the technical approch but also environmental impact. Recent research has been carried out to develop waterless fracturing technologies for EGS, including foam-based hydrofracking, where foams are mixtures of gas and liquid fluids. Foam fracturing fluids have potential benefits over water-based fluids because of less water consumption, less damage in water sensitive formations, and less liquid to recover and handle after fracturing process. One challenge for implementing foam fracturing in EGS is to achieve stable foams at high temperatures, as the foam stability tends to decay with increase in temperature.This research is focused on investigating the stability of foams at high temperatures. Preliminary results show that 1) N2 foams are more stable compared to CO2 foams, 2) foams containing only surfactants were not stable at high temperatures, and 3) addition of different stabilizing agents increased the thermal stability of all the foams. It was observed that different stabilizing agents interacted differently with anionic, nonionic, and cationic surfactants. It was further shown that the crosslinking agent with a base solution of pH 6 and graphene oxide dispersion was the most effective stabilizing agent for anionic surfactant AOS, while bentonite clay effectively enhanced thermal stability for another anionic surfactant SDS. SiO2 nanoparticles showed limited improvement in thermal stability at high temperatures compared to other stabilizing agents.
Presented by NETL at AGU Fall Meeting, 12/19
An embodiment of the invention is a shape memory polymer (SMP) foam designed to recover its original shape through exposure to a solvent. Thermo-responsive SMPs are polymers designed to maintain a programmed secondary shape until heated above their transition temperature, upon which the polymer recovers its original, or primary, shape. The thermo-responsive SMP foam is programmed to its secondary shape prior to use, typically compression of the foam to a small volume, and remains in this programmed shape until exposed to a selected solvent such as dimethyl sulfoxide or ethyl alcohol. Upon exposure to the solvent, the transition temperature of the SMP foam decreases below the temperature of the environment and the SMP foam actuates to its primary shape. The SMP foam is tailored to actuate upon exposure to specific solvents while minimizing or preventing actuation when exposed to water or other solvents. This selective solvent actuation can be used to increase working time of a SMP foam device, that is, the time allowed for use of a device without undesired actuation, while maintaining functional SMP actuation. Solvent actuated SMP foams can be used in various applications including, but not limited to, treatment of aneurysms and arterio-venous malformations, tissue engineering, and wound healing.
Abstract not provided.
The present invention provides a family of non-naturally occurring polypeptides having cholesterol efflux activity that parallels that of full-length apolipoproteins (e.g., Apo AI and Apo E), and having high selectivity for ABCA1 that parallels that of full-length apolipoproteins. Further, the peptides of the invention have little or no toxicity when administered at therapeutic and higher doses. The invention also provides compositions comprising such polypeptides, methods of identifying, screening and synthesizing such polypeptides, and methods of treating, preventing or diagnosing diseases and disorders associated with dyslipidemia, hypercholesterolemia, or inflammation; or diseases involving abnormal glucose metabolism, e.g., diabetes, metabolic syndrome; or Alzheimer's Disease or frontotemporal dementia.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Abstract not provided.
Explore the source record for details and available documents.
The present invention provides a family of non-naturally occurring polypeptides having cholesterol efflux activity that parallels that of full-length apolipoproteins (e.g., Apo AI and Apo E), and having high selectivity for ABCA1 that parallels that of full-length apolipoproteins. Further, the peptides of the invention have little or no toxicity when administered at therapeutic and higher doses. The invention also provides compositions comprising such polypeptides, methods of identifying, screening and synthesizing such polypeptides, and methods of treating, preventing or diagnosing diseases and disorders associated with dyslipidemia, hypercholesterolemia, or inflammation; or diseases involving abnormal glucose metabolism, e.g., diabetes, metabolic syndrome; or Alzheimers Disease or frontotemporal dementia.